Collectively, these results show that CD8+ T cells are the main effector cells for eradication of distal tumors as well as prevention of relapse at the primary site, while NK cells cooperate with CD8+ T cells to eliminate distal tumors, thus highlighting their distinct roles in regression of primary and metastatic tumors. The gene discussed is CD8A; the disease is metastatic neoplasm.